Loading...
Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study
BACKGROUND: Improved outcome in tobacco smoking patients with non‐small cell lung cancer (NSCLC) following immunotherapy has previously been reported. However, little is known regarding this association during first‐line immunotherapy in patients with high PD‐L1 expression. In this study we compared...
Saved in:
| Published in: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley & Sons Australia, Ltd
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7952794/ https://ncbi.nlm.nih.gov/pubmed/33527756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13852 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|